Literature DB >> 7235275

Pharmacokinetics and plasma binding of thiopental. II: Studies at cesarean section.

D J Morgan, G L Blackman, J D Paull, L J Wolf.   

Abstract

This study was undertaken to investigate the effect of pregnancy on the disposition of thiopental and to determine the major factors which influence the placental transfer of the drug to the fetus. Maternal venous (MV) and umbilical venous (UV) and arterial (UA) blood samples were collected at delivery from 11 pregnant women at term who received thiopental for induction of anesthesia for elective cesarian section. A detailed study of the pharmacokinetics of thiopental was carried out in 7 of these subjects and blood samples were collected for 80 to 100 hours following thiopental administration. A transient rise in thiopental plasma concentration was observed at delivery. Mean values of pharmacokinetic parameters (plus or minus SD) were: initial distribution volume (V1) 17.31 (plus or minus 8.5), apparent volume of distribution (Vdbeta) 564 1 (plus or minus 343), volume of distribution at steady state (Vss) 2881 (plus or minus 180), systemic plasma clearance (Clp) 0.286 l/min (plus or minus 0.156), rate of change of volume of distribution at zero time (RVd0) 1.03 l/min (plus or minus 0.36) and elimination half-life (t1/2) 26.1 h (plus or minus 12.6). Comparison of these data with our previously reported data in nonpregnant surgical patients shows that Vdbeta, Vss, T1/2 are significantly greater at cesarian section (P less than 0.05) and that systemic plasma clearance shows a similar trend. UA and UV values at delivery were similar within individuals. There was no correlation between the ratio UV/MV at delivery and the dosing-delivery interval (delta t), or between UV and the administered dose or delta t. There were good correlations between UV (corrected for dose) and the reciprocals of V1, Vdbeta, Vss, and plasma clearance of thiopental. This demonstrates that differences in maternal distribution and elimination characteristics of thiopental may be more important determinants of intersubject differences in fetal drug exposure than differences in dose or delta t.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7235275     DOI: 10.1097/00000542-198106000-00006

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  16 in total

Review 1.  Multiple peaking phenomena in pharmacokinetic disposition.

Authors:  Neal M Davies; Jody K Takemoto; Dion R Brocks; Jaime A Yáñez
Journal:  Clin Pharmacokinet       Date:  2010-06       Impact factor: 6.447

2.  [Drugs for intravenous induction of anesthesia: ketamine, midazolam and synopsis of current hypnotics].

Authors:  E Halbeck; C Dumps; D Bolkenius
Journal:  Anaesthesist       Date:  2018-08       Impact factor: 1.041

Review 3.  The significance of plasma protein binding on the fetal/maternal distribution of drugs at steady-state.

Authors:  M D Hill; F P Abramson
Journal:  Clin Pharmacokinet       Date:  1988-03       Impact factor: 6.447

Review 4.  Pharmacokinetic optimisation of general anaesthesia in pregnancy.

Authors:  T Gin
Journal:  Clin Pharmacokinet       Date:  1993-07       Impact factor: 6.447

5.  A survey of pharmacokinetic data from pregnant women.

Authors:  A J Cummings
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

6.  Elimination kinetics of thiopentone in mothers and their newborn infants.

Authors:  F Gaspari; G Marraro; G F Penna; R Valsecchi; M Bonati
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  Plasma binding of thiopentone in late pregnancy.

Authors:  D J Morgan; C T Toh; G L Blackman; J D Paull
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

Review 8.  Clinical pharmacokinetic considerations in the treatment of increased intracranial pressure.

Authors:  G Heinemeyer
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

Review 9.  Risk-benefit assessment of anaesthetic agents in the puerperium.

Authors:  J Kanto
Journal:  Drug Saf       Date:  1991 Jul-Aug       Impact factor: 5.606

10.  Variability of thiopental clearance in routine critical care patients.

Authors:  H Russo; J Brés; M P Duboin; B Roquefeuil
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.